Editor's Note Joint Commission International (JCI) and the International Hospital Federation's Geneva Sustainability Centre (GSC) have introduced a new Healthcare Sustainability Certification (HSC) for healthcare organizations outside the U.S., according to a September 11 report from The Joint Commission. The goal of the new initiative is to address the nearly…

Read More

Editor's Note Tubal ligation procedures increased after the 2022 overturn of Roe v. Wade and were particularly concentrated in states with abortion bans, according to a September 11 Associated Press (AP) report on a study published in JAMA. Researchers analyzed insurance claims for approximately 4.8 million women across 36 states…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated Baxter’s recall of certain Single Patient Use Circuits and Blue Ventilator Adapter Assemblies as Class 1, the most severe recall category indicating significant risk of injury or death. The Single Patient Use Circuit and Blue Adapter Assembly are patient circuit…

Read More

Asking who, what, why, when, where, and how—otherwise known as the “5 Ws and an H”— is a time-tested way for writers and researchers to ensure comprehensive coverage of any topic. Here, we apply this framework from the perspective of sterile processing department (SPD) professionals seeking to start a water…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Defibtech, LLC’s recall of RMU-2000 ARM XR Chest Compression Devices as Class 1, the most severe category indicating serious risk of injury or death. A motor issue could stop  compressions in adults whose hearts suddenly stop, according to the…

Read More

Editor's Note The US Food & Drug Administration (FDA) has approved immunotherapy durvalumab for perioperative treatment of resectable non-small cell lung cancer (NSCLC), according to an August 15 announcement. The approval is for durvalumab (Imfinzi, AstraZeneca) in combination with platinum-based chemotherapy as a neoadjuvant treatment, followed by durvalumab alone as…

Read More

Editor's Note The US Food and Drug Adminstration (FDA) has classified a recall of ICU Medical’s Plum 360, Plum A+ and Plum A+3 infusion pumps as Class 1, the most severe category indicating risk of serious injury or death. According to he agency’s August 20 announcement, the company is updating…

Read More

Editor's Note A bill in California that aims to increase oversight of private equity healthcare investments is receiving support from consumer advocates, labor unions, and the California Medical Association and opposition from hospitals worried about losing funding sources, the Los Angeles Times reported August 9. Sponsored by Attorney General Rob…

Read More

Editor's Note Planned Parenthood used the occasion of the Democratic National Convention in Chicago to offer free medication abortions and vasectomies at a mobile clinic, the Chicago Tribune reported August 19. According to the article, the group aims to demonstrate the possibilities of accessible reproductive healthcare when supported by favorable…

Read More

Editor's Note Medicare’s first negotiations on 10 top-selling prescription drugs for older Americans will save the US government $6 billion in the first year, according to an August 15 article in Reuters. Enabled by President Joe Biden’s 2022 Inflation Reduction Act, negotiations for drugs used by Medicare—which covers 66 million…

Read More